• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Roka Bioscience

edit

Roka Bioscience is dedicated to developing rapid, highly accurate molecular assays and instrument systems for the Food Safety Industry. Our newly released Atlas™ System represents a new tier of molecular rapid pathogen testing, offering automation and technology that bring true walk-away convenience and workflow advantages to the laboratory.

Roka is focused on creating novel testing solutions that help manufacturers mitigate risks, protect their brands, and meet the increasing testing demands now and for years to come.

Milestones

edit

• 
  Roka Bioscience added Steven T. Sobieski as Senior Vice President & CFO.
  Posted 7/28/11 at 6:18pm
• 
  Roka Bioscience added Paul G. Thomas as Founder & CEO.
  Posted 7/28/11 at 6:18pm
• 
  Roka Bioscience received $47.5M in Series D funding. (1/8/12)
  Posted 1/8/12 at 7:22pm via prnewswire.com
• 
  Roka Bioscience received $20M in Series C funding. (7/28/11)
  Posted 7/28/11 at 6:18pm via finsmes.com

Videos

Screenshots

edit

Above: Home Page
Uploaded: 2/29/12

Sources

1. Roka Bioscience Completes $20M Series C Equity Financing (finsmes.com) [edit]
2. Roka Bioscience Secures $47.5 Million in Series D Financing (prnewswire.com) [edit]